- Home
- OLED vs PCVX Comparison
OLED vs PCVX Comparison
Compare OLED & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLED
- PCVX
- Stock Information
- Founded
- OLED 1985
- PCVX 2013
- Country
- OLED United States
- PCVX United States
- Employees
- OLED N/A
- PCVX N/A
- Industry
- OLED Semiconductors
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- OLED Technology
- PCVX Health Care
- Exchange
- OLED Nasdaq
- PCVX Nasdaq
- Market Cap
- OLED 7.2B
- PCVX 4.4B
- IPO Year
- OLED 1992
- PCVX 2020
- Fundamental
- Price
- OLED $154.46
- PCVX $32.94
- Analyst Decision
- OLED Strong Buy
- PCVX Strong Buy
- Analyst Count
- OLED 7
- PCVX 10
- Target Price
- OLED $190.43
- PCVX $136.50
- AVG Volume (30 Days)
- OLED 531.5K
- PCVX 1.5M
- Earning Date
- OLED 07-31-2025
- PCVX 08-05-2025
- Dividend Yield
- OLED 1.16%
- PCVX N/A
- EPS Growth
- OLED 4.58
- PCVX N/A
- EPS
- OLED 4.81
- PCVX N/A
- Revenue
- OLED $648,702,000.00
- PCVX N/A
- Revenue This Year
- OLED $5.75
- PCVX N/A
- Revenue Next Year
- OLED $10.76
- PCVX N/A
- P/E Ratio
- OLED $32.18
- PCVX N/A
- Revenue Growth
- OLED 6.13
- PCVX N/A
- 52 Week Low
- OLED $103.70
- PCVX $27.66
- 52 Week High
- OLED $237.00
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- OLED 54.66
- PCVX 46.08
- Support Level
- OLED $148.80
- PCVX $32.06
- Resistance Level
- OLED $158.30
- PCVX $33.81
- Average True Range (ATR)
- OLED 3.65
- PCVX 1.23
- MACD
- OLED -0.45
- PCVX -0.12
- Stochastic Oscillator
- OLED 39.28
- PCVX 19.86
About OLED Universal Display Corporation
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.